MedTrace Logo

Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris

NCT03037047 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2017-01-31

No results posted yet for this study

Summary

This parallel, double blind, randomized, controlled, multi-center study will evaluate the efficacy and safety of salvianolate injection in elderly patients with unstable angina pectoris.

Conditions

  • Unstable Angina

Interventions

DRUG

0.9% Sodium Chloride Injection

Patients will treated with 0.9% Sodium Chloride Injection on the basis of conventional therapy for 14 days.

DRUG

salvianolate injection

Patients will treated with salvianolate injection on the basis of conventional therapy for 14 days.

Sponsors & Collaborators

  • Green Valley Group of China

    lead INDUSTRY

Principal Investigators

  • Xiaoying Li, doctor · Chinese PLA General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-11
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03037047 on ClinicalTrials.gov